Publications by authors named "Deborah Marcellus"

Claim this Profile
A
Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis.
Zeina Al-Mansour, Hongli Li, James R Cook, Louis S Constine, Stephen Couban, Deborah C Marcellus

Leuk Lymphoma· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704.
Soham D Puvvada, Patrick J Stiff, Michael Leblanc, James R Cook, Stephen Couban, Deborah Marcellus

Br J Haematol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma.
Patrick J Stiff, Joseph M Unger, James R Cook, Louis S Constine, Stephen Couban, Deborah Marcellus

N Engl J Med· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of ZD6474 (Zactima, a selective inhibitor of VEGFR and EGFR tyrosine kinase in patients with relapsed multiple myeloma--NCIC CTG IND.145.
Michael J Kovacs, Donna E Reece, Deborah Marcellus, Ralph M Meyer, Sarah Mathews

Invest New Drugs· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of age-related differences in quality of life preferences in patients with non-Hodgkin's lymphoma.
Tom Kouroukis, Ralph Meyer, Ann Benger, Deborah Marcellus, Ronan Foley

Leuk Lymphoma· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG).
Michael Crump, Tara Baetz, Stephen Couban, Andrew Belch, Deborah Marcellus

Cancer· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells.
Carol Ann Huff, Ephraim J Fuchs, Stephen J Noga, Paul V O'Donnell, Richard F Ambinder, Deborah Marcellus

Biol Blood Marrow Transplant· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of a transplantation strategy compared to melphalan and prednisone in younger patients with multiple myeloma.
C Tom Kouroukis, Bernie J O'Brien, Ann Benger, Deborah Marcellus, Ronan Foley

Leuk Lymphoma· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis